You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

Litigation Details for Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

✉ Email this page to a colleague

« Back to Dashboard

Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

Docket	⤷ Try a Trial	Date Filed	2020-06-09
Court	District Court, N.D. West Virginia	Date Terminated	2024-03-18
Cause	35:271 Patent Infringement	Assigned To	John Preston Bailey
Jury Demand	None	Referred To
Patents	8,318,802; 8,598,227
Link to Docket	External link to docket

Small Molecule Drugs cited in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Details for Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-06-09	1	Complaint (NOT for attorney use)	of United States Patent No. 8,318,802 (“the ’802 patent”) and United States Patent No. 8,598,227 (“the…the ’227 patent”) (collectively, “the patents-in-suit”). This action arises under the Patent Laws of …(Attachments: # 1 Exhibit A - Patent Information, # 2 Exhibit B - Patent Information, # 3 Civil Cover …the ’802 patent, titled “Epoprostenol Formulation and Method of Making Thereof.” The ’802 patent was duly…the ’802 patent is attached as Exhibit A. 17. Actelion owns the ’227 patent, titled	External link to document
2021-12-22	136	Certificate of Service	Ph.D. Regarding on Indefinitetness of U.S. Patent Nos. 8,318,802 and 8,598,227). (O'Brien, William) (Entered…2020 18 March 2024 1:20-cv-00110 835 Patent - Abbreviated New Drug Applications (ANDA)	External link to document
2022-02-14	143	Memorandum & Opinion	Actelion”), U.S. Patent Nos. 8,318,802 (the “’802 patent”) and 8,598,227 (the “’227 patent”) (collectively…CONSTRUCTION This patent infringement case involves two United States Patents owned by Actelion Pharmaceuticals… “It is a bedrock principle of patent law that the claims of a patent define the invention to which the…When construing patent claims, then, a court must consider the context of the entire patent, including both…unasserted claims. Id. at 1314. Because a patent will ordinarily use patent terms consistently, “the usage of	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.